… , or predictive biomarkers. They may also serve as targets for treating gastric cancer. In this
… make them potential biomarkers for the diagnosis and prognosis of gastric cancer. Relatively…

… biomarkers of gastric cancer (GC) testing the following hypotheses: are these biomarkers …
significance, and should any of these biomarkers be considered to tailor patient treatment in …

… biomarkers evaluated in GC and their role as a guide for treatment for precision medicine. …
2 overexpression represents the only predictive molecular biomarker validated in GC, while its …

… value of other biomarkers before new drugs are incorporated into clinical practice. … for certain
biomarkers provides a roadmap to implement genome-guided personalized therapy for GC. …

Gastric cancer (GC) is a leading cause of worldwide cancer-… In addition, a series of diagnositc
and prognostic biomarkers … PD risk and research advances in PD-associated biomarkers. …

… We also explore future perspectives, including predictive biomarkers and novel signaling …
Results specific for advanced gastric cancer, as opposed to early gastric cancer or cell lines, …

… biomarkers is relatively limited. Personalized medicine based on predictive biomarkers is …
The aim of this review is to provide up-to-date information about predictive biomarkers for …

… Although efforts have been made to clarify the molecular basis for the diversity of tumor
phenotypes and identify biomarkers and therapeutic targets, precision medicine for GC is still in …

… Despite various obstacles, advanced technology and genomics have led to the development
of personalized and precision medicine. Combinations of approved biomarkers will allow …

… studies, biomarker identification, drug screening, and preclinical evaluation of personalized
medicine … methods and apply them to individual GC patients in the era of precision medicine. …